Lymph node metastasis in a gynecologic malignancy.

Area of Science:

• Gynecologic Oncology
• Surgical Pathology
• Cancer Staging

Background:

• Histopathological parameters are crucial prognostic indicators in cervical cancer (Stage IA2-IIB).
• Pelvic lymph node (PLN) metastasis is increasingly recognized in ovarian cancer staging, though its prognostic significance remains debated.
• Individualizing pelvic lymph node dissection is a key consideration in endometrial cancer management.

Purpose of the Study:

• To investigate the relationship between pelvic lymph node metastasis and various prognostic factors in cervical, endometrial, and ovarian cancers.
• To analyze the prognostic significance of lymph node metastasis across different gynecologic malignancies.
• To explore the potential for individualized pelvic lymph node dissection strategies.

Main Methods:

• Retrospective analysis of prognostic variables in patients undergoing radical hysterectomy for cervical cancer.
• Review of literature and clinical data concerning lymph node involvement in ovarian and endometrial cancers.
• Comparative analysis of histopathological parameters and their correlation with lymph node metastasis.

Main Results:

• Multiple histopathological factors (e.g., tumor diameter, invasion depth, LVSI) are established prognosticators in cervical cancer.
• The prognostic role of lymph node metastasis in ovarian cancer requires further clarification despite its inclusion in FIGO staging.
• The study establishes a basis for understanding PLN metastasis patterns across cervical, endometrial, and ovarian cancers.

Conclusions:

• Understanding the interplay of prognostic variables, including lymph node metastasis, is essential for tailoring treatment in gynecologic cancers.
• Further research is warranted to refine staging and treatment protocols based on lymph node status.
• Individualized surgical approaches, particularly concerning pelvic lymph node dissection, may be optimized through comprehensive prognostic factor analysis.